Evoqua Water Technologies Stock Price, News & Analysis (NYSE:AQUA)

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evoqua Water Technologies in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AQUA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AQUA, but not buy additional shares or sell existing shares.
View AQUA analyst ratings or view top-rated stocks.

3 analysts have issued 1-year price objectives for Evoqua Water Technologies' shares. Their AQUA share price targets range from $49.00 to $55.00. On average, they anticipate the company's stock price to reach $51.50 in the next year. This suggests a possible upside of 3.2% from the stock's current price.
View analysts price targets for AQUA or view top-rated stocks among Wall Street analysts.

Evoqua Water Technologies Corp. (NYSE:AQUA) issued its quarterly earnings data on Tuesday, November, 16th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.03. The business had revenue of $425.90 million for the quarter, compared to analysts' expectations of $414.20 million. Evoqua Water Technologies had a trailing twelve-month return on equity of 16.97% and a net margin of 4.24%. Evoqua Water Technologies's revenue was up 10.9% on a year-over-year basis. During the same period last year, the business earned $0.27 EPS.

Gabelli Love Our Planet & People ETF holds 6,414 shares of AQUA stock, representing 2.50% of its portfolio.

85 employees have rated Evoqua Water Technologies Chief Executive Officer Ronald C. Keating on Glassdoor.com. Ronald C. Keating has an approval rating of 54% among the company's employees. This puts Ronald C. Keating in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Evoqua Water Technologies investors own include Melinta Therapeutics (MLNT), Cara Therapeutics (CARA), AT&T (T), Pfizer (PFE), Marvell Technology (MRVL), PayPal (PYPL), AbbVie (ABBV), Walt Disney (DIS), Roku (ROKU) and Exxon Mobil (XOM).

(AQUA) raised $500 million in an initial public offering (IPO) on Thursday, November 2nd 2017. The company issued 27,800,000 shares at a price of $17.00-$19.00 per share. Credit Suisse, J.P. Morgan and RBC Capital Markets served as the underwriters for the IPO and Citigroup, Goldman Sachs, Morgan Stanley, Baird, Raymond James, Stifel and Wells Fargo Securities were co-managers.